Filter

Refine by collections

Refine by date

—

Refine by access

  • Print
  • Save

Search Results

You are looking at 1 - 10 of 22 items for :

  • "radioactive iodine refractory thyroid cancer" x
  • Refine by access: All content x
Clear All
Chen Wang Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

Search for other papers by Chen Wang in
Google Scholar
PubMed Close
,
Xin Zhang Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

Search for other papers by Xin Zhang in
Google Scholar
PubMed Close
,
Xue Yang Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, China

Search for other papers by Xue Yang in
Google Scholar
PubMed Close
,
Hui Li Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

Search for other papers by Hui Li in
Google Scholar
PubMed Close
,
Ruixue Cui Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

Search for other papers by Ruixue Cui in
Google Scholar
PubMed Close
,
Wenmin Guan Department of Radiology, Peking Union Medical College Hospital, Beijing, China

Search for other papers by Wenmin Guan in
Google Scholar
PubMed Close
,
Xin Li Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou, China

Search for other papers by Xin Li in
Google Scholar
PubMed Close
,
Zhaohui Zhu Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

Search for other papers by Zhaohui Zhu in
Google Scholar
PubMed Close
, and
Yansong Lin Department of Nuclear Medicine, Peking Union Medical College Hospital, Beijing, China
Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, China

Search for other papers by Yansong Lin in
Google Scholar
PubMed Close

. Journal of Nuclear Medicine 58 258 – 265 . ( https://doi.org/10.2967/jnumed.116.180240 ) 10.2967/jnumed.116.180240 Zhao D Jin X Li F Liang J Lin Y 2012 Integrin alphavbeta3 imaging of radioactive iodine-refractory thyroid cancer using 99 mTc-3

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-18-0007
Volume/Issue:
Volume 25: Issue 6
Free access
Ana Albero Department of Oncology, Andalusian Agency for Health Technology Assessment (AETSA), Department of Endocrinology and Nutrition, University Hospital ‘Virgen Macarena’, Seville, Spain

Search for other papers by Ana Albero in
Google Scholar
PubMed Close
,
Juliana Ester Lopéz Department of Oncology, Andalusian Agency for Health Technology Assessment (AETSA), Department of Endocrinology and Nutrition, University Hospital ‘Virgen Macarena’, Seville, Spain

Search for other papers by Juliana Ester Lopéz in
Google Scholar
PubMed Close
,
Alberto Torres Department of Oncology, Andalusian Agency for Health Technology Assessment (AETSA), Department of Endocrinology and Nutrition, University Hospital ‘Virgen Macarena’, Seville, Spain

Search for other papers by Alberto Torres in
Google Scholar
PubMed Close
,
Luis de la Cruz Department of Oncology, Andalusian Agency for Health Technology Assessment (AETSA), Department of Endocrinology and Nutrition, University Hospital ‘Virgen Macarena’, Seville, Spain

Search for other papers by Luis de la Cruz in
Google Scholar
PubMed Close
, and
Tomas Martín Department of Oncology, Andalusian Agency for Health Technology Assessment (AETSA), Department of Endocrinology and Nutrition, University Hospital ‘Virgen Macarena’, Seville, Spain

Search for other papers by Tomas Martín in
Google Scholar
PubMed Close

In differentiated thyroid carcinoma refractory to radioactive iodine (CDT-RTI), chemotherapy has been considered for decades to be the only systemic therapy with palliative purpose. Phase II studies assessing the efficacy of different chemotherapy outlines have been published. Nevertheless, phase III studies in these tumours have not been performed. Our objective is to evaluate the effectiveness of chemotherapy in patients with CDT-RTI by a systematic review of published studies. Systematic research of the literature in Medline and Embase databases (among others) was carried out. The full texts of selected references were analysed by two independent reviewers and then assessed for risk of bias in each study. We also extracted data using specifically designed questionnaires. Later, a qualitative synthesis of results was performed and pooled data were calculated. We found that 16 studies with 473 patients published in the last 40 years were included out of 509 identified references in databases. Thirteen studies (176 patients) included data on response to treatment and histology. Four studies included 70 patients only with well-differentiated non-medullary tumours. Response rate (RR) was 22.1% (0–57%) for 13 studies, 25% for the 176 patients and 27.1% for the 70 patients, with 2.5, 3.4 and 2.8% complete responses respectively. Survival times could not be assessed or pooled due to the lack of data and heterogeneity of the studies, and was determined to have a high risk of bias. Although it has not been possible to find solid evidence about the efficacy of chemotherapy, the results shown indicate that it may have some effectiveness, although this should be proven with well-designed studies using modern drugs.

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0194
Volume/Issue:
Volume 23: Issue 2
Free access
Peter M Sadow Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA
Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA

Search for other papers by Peter M Sadow in
Google Scholar
PubMed Close
,
Dora Dias-Santagata Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA

Search for other papers by Dora Dias-Santagata in
Google Scholar
PubMed Close
,
Zongli Zheng Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA

Search for other papers by Zongli Zheng in
Google Scholar
PubMed Close
,
Derrick T Lin Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA

Search for other papers by Derrick T Lin in
Google Scholar
PubMed Close
,
Long Phi Le Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA

Search for other papers by Long Phi Le in
Google Scholar
PubMed Close
, and
Carmelo Nucera Department of Pathology, WRN219, Harvard Medical School, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts, 02114, USA

Search for other papers by Carmelo Nucera in
Google Scholar
PubMed Close

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1 . Cancer Research 69 4885 – 4893 . ( doi:10.1158/0008-5472.CAN-09-0727 ). Rosove MH Peddi

Article Type:
Letter
DOI:
https://doi.org/10.1530/ERC-15-0198
Volume/Issue:
Volume 22: Issue 6
Free access
Camille Buffet Sorbonne Université, Unité Thyroïde-Tumeurs endocrine, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France

Search for other papers by Camille Buffet in
Google Scholar
PubMed Close
,
Johanna Wassermann Sorbonne Université, Service d’Oncologie, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France

Search for other papers by Johanna Wassermann in
Google Scholar
PubMed Close
,
Fabio Hecht Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brazil

Search for other papers by Fabio Hecht in
Google Scholar
PubMed Close
,
Laurence Leenhardt Sorbonne Université, Unité Thyroïde-Tumeurs endocrine, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France

Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed Close
,
Corinne Dupuy UMR 8200 CNRS, Villejuif, France
Université Paris-Saclay et Gustave Roussy, Villejuif, France

Search for other papers by Corinne Dupuy in
Google Scholar
PubMed Close
,
Lionel Groussin INSERM Unité 1016, CNRS, UMR 8104, Institut Cochin, Paris, France
Université de Paris, Paris, France
Department of Endocrinology, APHP, Cochin Hospital, Paris, France

Search for other papers by Lionel Groussin in
Google Scholar
PubMed Close
, and
Charlotte Lussey-Lepoutre Sorbonne Université, Service de Médecine Nucléaire, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
PARCC, INSERM, Equipe Labellisée par la Ligue contre le Cancer, Paris, France

Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed Close

) Pak K Shin S Kim SJ Kim IJ Chang S Koo P Kwak J Kim JH 2018 Response of retinoic acid in patients with radioactive iodine-refractory thyroid cancer: a meta-analysis . Oncology Research and Treatment 41 100 – 104 . ( https

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-19-0491
Volume/Issue:
Volume 27: Issue 5
Free access
D Deandreis Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by D Deandreis in
Google Scholar
PubMed Close
,
A Al Ghuzlan Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by A Al Ghuzlan in
Google Scholar
PubMed Close
,
S Leboulleux Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by S Leboulleux in
Google Scholar
PubMed Close
,
L Lacroix Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by L Lacroix in
Google Scholar
PubMed Close
,
J P Garsi Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by J P Garsi in
Google Scholar
PubMed Close
,
M Talbot Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by M Talbot in
Google Scholar
PubMed Close
,
J Lumbroso Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by J Lumbroso in
Google Scholar
PubMed Close
,
E Baudin Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by E Baudin in
Google Scholar
PubMed Close
,
B Caillou Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by B Caillou in
Google Scholar
PubMed Close
,
J M Bidart Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by J M Bidart in
Google Scholar
PubMed Close
, and
M Schlumberger Department of Nuclear Medicine and Endocrine Oncology, Department of Pathology and Clinical Biology, Unit 605, National Institute of Health and Medical Research, Institut Gustave Roussy and University Paris Sud, 39 Rue Camille Desmoulins, 94805 Villejuif, France

Search for other papers by M Schlumberger in
Google Scholar
PubMed Close

D Knauf JA Tuttle RM 2009 Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancer reveals distinct pathogenetic roles of BRAF, PIK3CA and AKT1 . Cancer Research 69 4885 – 4893 doi:10

Article Type:
Research Article
DOI:
https://doi.org/10.1677/ERC-10-0233
Volume/Issue:
Volume 18: Issue 1
Free access
Devora Champa
Search for other papers by Devora Champa in
Google Scholar
PubMed Close
,
Marika A Russo
Search for other papers by Marika A Russo in
Google Scholar
PubMed Close
,
Xiao-Hui Liao Department of Developmental and Molecular Biology, Departments of Medicine, Pediatrics and Committee on Genetics, Department of Pathology, Albert Einstein College of Medicine, Price Center for Genetic and Translational Medicine, 1301 Morris Park Avenue, Room 302, Bronx, New York 10461, USA

Search for other papers by Xiao-Hui Liao in
Google Scholar
PubMed Close
,
Samuel Refetoff Department of Developmental and Molecular Biology, Departments of Medicine, Pediatrics and Committee on Genetics, Department of Pathology, Albert Einstein College of Medicine, Price Center for Genetic and Translational Medicine, 1301 Morris Park Avenue, Room 302, Bronx, New York 10461, USA
Department of Developmental and Molecular Biology, Departments of Medicine, Pediatrics and Committee on Genetics, Department of Pathology, Albert Einstein College of Medicine, Price Center for Genetic and Translational Medicine, 1301 Morris Park Avenue, Room 302, Bronx, New York 10461, USA

Search for other papers by Samuel Refetoff in
Google Scholar
PubMed Close
,
Ronald A Ghossein Department of Developmental and Molecular Biology, Departments of Medicine, Pediatrics and Committee on Genetics, Department of Pathology, Albert Einstein College of Medicine, Price Center for Genetic and Translational Medicine, 1301 Morris Park Avenue, Room 302, Bronx, New York 10461, USA

Search for other papers by Ronald A Ghossein in
Google Scholar
PubMed Close
, and
Antonio Di Cristofano
Search for other papers by Antonio Di Cristofano in
Google Scholar
PubMed Close

500 – 501 . ( doi:10.1038/ng0506-500 ). Ricarte-Filho JC Ryder M Chitale DA Rivera M Heguy A Ladanyi M Janakiraman M Solit D Knauf JA Tuttle RM 2009 Mutational profile of advanced primary and metastatic radioactive iodine-refractory

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-14-0268
Volume/Issue:
Volume 21: Issue 5
Free access
Gahee Park Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Gahee Park in
Google Scholar
PubMed Close
,
Tae Hyuk Kim Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Tae Hyuk Kim in
Google Scholar
PubMed Close
,
Hae-Ock Lee Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Hae-Ock Lee in
Google Scholar
PubMed Close
,
Jung Ah Lim Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Jung Ah Lim in
Google Scholar
PubMed Close
,
Jae-Kyung Won Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Jae-Kyung Won in
Google Scholar
PubMed Close
,
Hye Sook Min Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Hye Sook Min in
Google Scholar
PubMed Close
,
Kyu Eun Lee Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Kyu Eun Lee in
Google Scholar
PubMed Close
,
Do Joon Park Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Do Joon Park in
Google Scholar
PubMed Close
,
Young Joo Park Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Young Joo Park in
Google Scholar
PubMed Close
, and
Woong-Yang Park Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of
Samsung Genome Institute, Internal Medicine, Surgery, Biomedical Sciences, Department of Internal Medicine, Department of Molecular Cell Biology, Samsung Medical Center, 50 Irwondong, Gangnamgu, Seoul 135-710, Korea Departments of

Search for other papers by Woong-Yang Park in
Google Scholar
PubMed Close

supports the molecular phenotype-stratified approach to cancer care ( Willyard 2013 ). In patients with radioactive-iodine-refractory thyroid cancer, the use of practical diagnostic methodology such as IHC to identify patients with rearrangements of ALK

Article Type:
Research Article
DOI:
https://doi.org/10.1530/ERC-14-0467
Volume/Issue:
Volume 22: Issue 1
Free access
Marie-Claude Hofmann Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Marie-Claude Hofmann in
Google Scholar
PubMed Close
,
Muthusamy Kunnimalaiyaan Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Muthusamy Kunnimalaiyaan in
Google Scholar
PubMed Close
,
Jennifer R Wang Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Jennifer R Wang in
Google Scholar
PubMed Close
,
Naifa L Busaidy Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Naifa L Busaidy in
Google Scholar
PubMed Close
,
Steven I Sherman Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Steven I Sherman in
Google Scholar
PubMed Close
,
Stephen Y Lai Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Stephen Y Lai in
Google Scholar
PubMed Close
,
Mark Zafereo Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Mark Zafereo in
Google Scholar
PubMed Close
, and
Maria E Cabanillas Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Search for other papers by Maria E Cabanillas in
Google Scholar
PubMed Close

Theodon H Bessiene L Bricaire L Bonnet-Serrano F Cochand-Priollet B Leroy K Garinet S Pasmant E Zerbit J 2022 Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer . Thyroid 32

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-22-0129
Volume/Issue:
Volume 29: Issue 11
Free access
Anna Angelousi 1st Department of Internal Medicine, Unit of Endocrinology, Laikon Hospital, Athens, Greece

Search for other papers by Anna Angelousi in
Google Scholar
PubMed Close
,
Ploutarchos Tzoulis Department of Metabolism & Experimental Therapeutics, Division of Medicine, University College London, London, UK

Search for other papers by Ploutarchos Tzoulis in
Google Scholar
PubMed Close
,
Marina Tsoli 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Marina Tsoli in
Google Scholar
PubMed Close
,
Eleftherios Chatzellis 251 HAF and VA Hospital, Athens, Greece

Search for other papers by Eleftherios Chatzellis in
Google Scholar
PubMed Close
,
Anna Koumarianou Fourth Department of Internal Medicine, Hematology Oncology Unit, Attikon University Hospital, National and Kapodistrian University of Athens, Greece

Search for other papers by Anna Koumarianou in
Google Scholar
PubMed Close
, and
Gregory Kaltsas 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed Close

II trial of nivolumab plus ipilimumab in radioactive iodine-refractory thyroid cancer with exploratory cohorts in ATC and MTC Nivolumab plus ipilimumab, phase II (active, not recruiting) Metastatic thyroid cancer, including radioactive iodine

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-23-0296
Volume/Issue:
Volume 31: Issue 4
Restricted access
Fernanda Vaisman
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed Close
,
Denise P Carvalho Endocrinology Service, Laboratório de Fosiologia Endócrina Doris Rosental, Endocrinology Service, National Cancer Institute, Brazil Praça da Cruz Vermelha, 23, 8° Floor, Centro, Rio de Janeiro, Rio de Janeiro, 20230-130, Brazil

Search for other papers by Denise P Carvalho in
Google Scholar
PubMed Close
, and
Mario Vaisman Endocrinology Service, Laboratório de Fosiologia Endócrina Doris Rosental, Endocrinology Service, National Cancer Institute, Brazil Praça da Cruz Vermelha, 23, 8° Floor, Centro, Rio de Janeiro, Rio de Janeiro, 20230-130, Brazil

Search for other papers by Mario Vaisman in
Google Scholar
PubMed Close

2009 Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1 . Cancer Research 69 4885 – 4893 . ( doi:10.1158/0008-5472.CAN-09

Article Type:
Review Article
DOI:
https://doi.org/10.1530/ERC-15-0300
Volume/Issue:
Volume 22: Issue 6
Free access